Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
7.00
Ask:
11.00
Spread: 4.00 (57.143%)
Market Cap: £2.98m
HYG Live PriceLast checked at - London Stock Exchange

Intraday Seneca Growth Share Chart

Offer to shareholders

19 Mar 2008 17:02

Hygea VCT plc19 March 2008 FOR IMMEDIATE RELEASE 19 MARCH 2008 HYGEA VCT ('Hygea' or the 'Company') Offer to shareholders The Board of Hygea has, on 18 March 2008, posted a letter to shareholderssetting out their proposals to raise additional funds for the Company to provideit with additional investment monies for existing investee companies and workingcapital by means of an offer to shareholders ("the Offer"). At the last Annual General Meeting, the shareholders authorised the Board toissue additional shares in the capital of the Company up to a maximum of 10% ofthe issued share capital. Accordingly, the Company are able to issue up to750,000 new Ordinary Shares at an issue price will be 50p per share. If theissue is fully subscribed the Company will receive in excess of £360,000 net ofexpenses. Details of the Offer: 1. the Offer will close on Wednesday 30 April 2008 at 5pm and an allotment willbe made then, but an earlier allotment will also be made by the Board onWednesday 2 April 2008 at 5pm in respect of received application forms in orderto assist those earlier subscribers looking to qualify for tax relief in respectof the 2007/08 tax year; 2. although the Board is discussing the Offer with certain outside investors,existing shareholders will be given priority at the first and second allotmentstage in respect of allocations made at each time; 3. the majority of Directors intend to apply for shares and this may be inexcess of their existing percentage ownership of the Company; 4. the audited accounts of the Company for the year ended 31st December 2007 areexpected to be published on or around Tuesday 18th March; 5. since the aggregate value of shares offered is less than €2.5m, there is norequirement under Part VI of the Financial Services and Markets Act 2000 for aprospectus to be issued. Application will be made to the UK Listing Authority for the new OrdinaryShares, which will rank pari passu, with all existing Ordinary Shares to beadmitted to the Official List. Application will also be made to London StockExchange plc for the new Ordinary Shares to be admitted to trading on its marketfor listed securities. It is expected that admission to trading will becomeeffective and will commence within 10 days of both the allotments made on 2April 2008 and 30 April 2008. Expected timetable: Offer closes 30 April 2008First Allotment of new ordinary shares 2 April 2008Final Allotment of new ordinary shares 30 April 2008Dealings in new ordinary shares commence Within 10 days of each allotmentDefinitive share certificates dispatched Within 15 days of each allotment Enquiries: Charles Breese, Hygea VCT plc on 01280 703482 or larpentnewton@btinternet.com Roland Cornish, Beaumont Cornish Limited on 020 7628 3396 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20261:34 pmRNSResults of Annual General Meeting voting
30th Apr 202612:12 pmRNSAnnual Report, Notice of AGM and new NAVs
20th Mar 20264:36 pmRNSUnaudited Net asset value (“NAV”) Update
28th Nov 202512:06 pmRNSShare Buy-back and Total Voting Rights
11th Nov 202512:11 pmRNSSecond Interim Dividend on B Shares
21st Oct 20252:40 pmRNSPDMR Shareholding
15th Oct 20254:26 pmRNSUpdated NAV & Ordinary Share Class Dividend
26th Sep 20251:50 pmRNSUnaudited Half-year Report for 6m to 30 June 2025
8th Aug 20254:05 pmRNSIssue of Equity and Total Voting Rights
2nd Jun 20253:15 pmRNSShare Buy-back and Total Voting Rights
22nd May 20251:20 pmRNSResult of AGM
12th May 20254:02 pmRNSInterim Capital Dividend on Ordinary Shares
7th May 20253:04 pmRNSIssue of Equity and Total Voting Rights
29th Apr 20253:58 pmRNSIssue of Supplementary Prospectus
23rd Apr 20254:15 pmRNSFinal results and Notice of AGM
4th Apr 20253:37 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20257:00 amRNSNet Asset Value(s)
19th Mar 20257:00 amRNSInterim Dividend on B Shares
11th Dec 20242:44 pmRNSDirector/PDMR Dealing
11th Dec 20242:39 pmRNSIssue of Equity and Total Voting Rights
15th Nov 20243:15 pmRNSShare Buy-back and Total Voting Rights
14th Nov 20243:32 pmRNSSecond Interim Dividend on B Shares
16th Oct 20247:00 amRNSNet Asset Value(s)
12th Sep 20242:11 pmRNSOffer for Subscription and Prospectus Publication
9th Aug 20243:20 pmGNWIssue of Equity and Total Voting Rights
6th Aug 202410:10 amGNWClosure of Offer for Subscription
25th Jul 20247:00 amGNWHalf-year Report
15th May 202412:16 pmGNWResult of AGM
1st May 20243:34 pmGNWIssue of Equity and Total Voting Rights
1st May 20247:00 amGNWB Share Net Asset Value
22nd Apr 202410:46 amGNWShare Buy-back and Total Voting Rights
5th Apr 202412:44 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20247:00 amGNWNet Asset Value(s)
28th Mar 202412:11 pmGNWIssue of Supplementary Prospectus
22nd Mar 20247:00 amGNWFinal Results, Notice of AGM, Updated NAV
7th Mar 20247:00 amGNWInterim Dividend on B Shares
19th Feb 20244:36 pmGNWDirector Declaration
21st Dec 202312:03 pmGNWIssue of Equity and Total Voting Rights
6th Dec 20233:24 pmGNWDirector/PDMR Dealing
6th Dec 20233:14 pmGNWIssue of Equity and Total Voting Rights
29th Nov 202312:36 pmGNWChange of the Company’s Auditor
20th Nov 20233:20 pmGNWB Share Buy-back and Total Voting Rights
3rd Nov 20237:00 amGNWDividend Declaration
12th Oct 20237:00 amGNWNet Asset Value(s)
11th Oct 20233:39 pmGNWDirectorate Change
24th Aug 20234:18 pmGNWOffer for Subscription and Publication of Prospectus
18th Aug 20235:08 pmGNWIssue of Equity and Total Voting Rights and Capital Reorganisation
2nd Aug 202311:40 amGNWHalf-year Report
30th Jun 20231:58 pmGNWIssue of Equity and Total Voting Rights
20th Jun 20238:50 amGNWShare Buy-back and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.